Phyllome
1 known investors
Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
AgTechBiotechFoodTech
Investors · 1
Frequently asked questions
- What does Phyllome do?
- Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
- Who are Phyllome's investors?
- Phyllome's investors include Tenacious Ventures.